American Bio Medica Corporation (ABMC)
USD 0.0
(9900.0%)
USD 0.0
(9900.0%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2022 | 379 Thousand USD | -14.45% |
| 2021 | 443 Thousand USD | -17.35% |
| 2020 | 536 Thousand USD | -33.83% |
| 2019 | 810 Thousand USD | -20.51% |
| 2018 | 1.01 Million USD | -30.82% |
| 2017 | 1.47 Million USD | -6.89% |
| 2016 | 1.58 Million USD | -9.39% |
| 2015 | 1.74 Million USD | 1.39% |
| 2014 | 1.72 Million USD | -16.85% |
| 2013 | 2.07 Million USD | -19.45% |
| 2012 | 2.57 Million USD | -20.62% |
| 2011 | 3.23 Million USD | -10.13% |
| 2010 | 3.6 Million USD | -16.48% |
| 2009 | 4.31 Million USD | -22.28% |
| 2008 | 5.55 Million USD | 11.17% |
| 2007 | 4.99 Million USD | 2.78% |
| 2006 | 4.85 Million USD | 9.34% |
| 2005 | 4.44 Million USD | 2.44% |
| 2004 | 4.33 Million USD | 42.28% |
| 2003 | 3.04 Million USD | 9.09% |
| 2002 | 2.79 Million USD | 33.92% |
| 2001 | 2.08 Million USD | 56.68% |
| 2000 | 1.33 Million USD | -27.37% |
| 1999 | 1.83 Million USD | 83.4% |
| 1998 | 1 Million USD | 49.54% |
| 1997 | 668.72 Thousand USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 Q3 | - USD | 0.0% |
| 2023 Q1 | 98 Thousand USD | -74.14% |
| 2023 Q2 | - USD | -100.0% |
| 2022 FY | 379 Thousand USD | -14.45% |
| 2022 Q1 | 419 Thousand USD | -5.42% |
| 2022 Q2 | 401 Thousand USD | -4.3% |
| 2022 Q3 | 380 Thousand USD | -5.24% |
| 2022 Q4 | 379 Thousand USD | -0.26% |
| 2021 FY | 443 Thousand USD | -17.35% |
| 2021 Q1 | 507 Thousand USD | -5.41% |
| 2021 Q2 | 475 Thousand USD | -6.31% |
| 2021 Q3 | 419 Thousand USD | -11.79% |
| 2021 Q4 | 443 Thousand USD | 5.73% |
| 2020 Q4 | 536 Thousand USD | -10.96% |
| 2020 FY | 536 Thousand USD | -33.83% |
| 2020 Q2 | 769 Thousand USD | 6.36% |
| 2020 Q3 | 602 Thousand USD | -21.72% |
| 2020 Q1 | 723 Thousand USD | -10.74% |
| 2019 Q2 | 825 Thousand USD | -15.21% |
| 2019 FY | 810 Thousand USD | -20.51% |
| 2019 Q1 | 973 Thousand USD | -4.51% |
| 2019 Q4 | 810 Thousand USD | -8.99% |
| 2019 Q3 | 890 Thousand USD | 7.88% |
| 2018 Q1 | 1.38 Million USD | -5.77% |
| 2018 Q3 | 1.25 Million USD | -0.87% |
| 2018 Q2 | 1.26 Million USD | -9.15% |
| 2018 Q4 | 1.01 Million USD | -18.48% |
| 2018 FY | 1.01 Million USD | -30.82% |
| 2017 Q4 | 1.47 Million USD | 0.75% |
| 2017 Q1 | 1.5 Million USD | -4.99% |
| 2017 Q3 | 1.46 Million USD | 0.83% |
| 2017 FY | 1.47 Million USD | -6.89% |
| 2017 Q2 | 1.45 Million USD | -3.53% |
| 2016 Q1 | 1.62 Million USD | -7.16% |
| 2016 Q3 | 1.55 Million USD | -3.35% |
| 2016 Q4 | 1.58 Million USD | 1.67% |
| 2016 FY | 1.58 Million USD | -9.39% |
| 2016 Q2 | 1.61 Million USD | -0.68% |
| 2015 FY | 1.74 Million USD | 1.39% |
| 2015 Q4 | 1.74 Million USD | -5.52% |
| 2015 Q1 | 1.81 Million USD | 5.23% |
| 2015 Q2 | 1.82 Million USD | 0.66% |
| 2015 Q3 | 1.84 Million USD | 1.32% |
| 2014 Q1 | 1.96 Million USD | -5.07% |
| 2014 FY | 1.72 Million USD | -16.85% |
| 2014 Q2 | 1.92 Million USD | -1.88% |
| 2014 Q3 | 1.85 Million USD | -3.99% |
| 2014 Q4 | 1.72 Million USD | -7.02% |
| 2013 FY | 2.07 Million USD | -19.45% |
| 2013 Q1 | 2.47 Million USD | -3.62% |
| 2013 Q2 | 2.48 Million USD | 0.12% |
| 2013 Q3 | 2.17 Million USD | -12.29% |
| 2013 Q4 | 2.07 Million USD | -4.83% |
| 2012 FY | 2.57 Million USD | -20.62% |
| 2012 Q1 | 3.31 Million USD | 2.28% |
| 2012 Q3 | 3.07 Million USD | -9.17% |
| 2012 Q2 | 3.39 Million USD | 2.32% |
| 2012 Q4 | 2.57 Million USD | -16.5% |
| 2011 Q4 | 3.23 Million USD | 1.98% |
| 2011 FY | 3.23 Million USD | -10.13% |
| 2011 Q3 | 3.17 Million USD | -1.4% |
| 2011 Q2 | 3.22 Million USD | -4.96% |
| 2011 Q1 | 3.38 Million USD | -5.97% |
| 2010 Q2 | 4 Million USD | 0.3% |
| 2010 Q3 | 3.75 Million USD | -6.25% |
| 2010 Q1 | 3.98 Million USD | -7.56% |
| 2010 Q4 | 3.6 Million USD | -3.92% |
| 2010 FY | 3.6 Million USD | -16.48% |
| 2009 Q4 | 4.31 Million USD | -2.02% |
| 2009 Q1 | 5.02 Million USD | -9.56% |
| 2009 Q2 | 4.46 Million USD | -11.15% |
| 2009 Q3 | 4.4 Million USD | -1.28% |
| 2009 FY | 4.31 Million USD | -22.28% |
| 2008 FY | 5.55 Million USD | 11.17% |
| 2008 Q3 | 5.43 Million USD | 4.86% |
| 2008 Q1 | 5.07 Million USD | 1.58% |
| 2008 Q4 | 5.55 Million USD | 2.19% |
| 2008 Q2 | 5.18 Million USD | 2.13% |
| 2007 Q2 | 4.79 Million USD | -6.24% |
| 2007 Q4 | 4.99 Million USD | 18.45% |
| 2007 FY | 4.99 Million USD | 2.78% |
| 2007 Q1 | 5.11 Million USD | 5.19% |
| 2007 Q3 | 4.21 Million USD | -12.02% |
| 2006 Q2 | 3.7 Million USD | -5.68% |
| 2006 Q1 | 3.92 Million USD | -11.59% |
| 2006 Q3 | 3.97 Million USD | 7.31% |
| 2006 Q4 | 4.85 Million USD | 22.18% |
| 2006 FY | 4.85 Million USD | 9.34% |
| 2005 Q2 | 3.97 Million USD | -5.96% |
| 2005 FY | 4.44 Million USD | 2.44% |
| 2005 Q4 | 4.44 Million USD | 0.02% |
| 2005 Q1 | 4.22 Million USD | -2.56% |
| 2005 Q3 | 4.44 Million USD | 11.77% |
| 2004 Q2 | 3.01 Million USD | -2.93% |
| 2004 Q1 | 3.1 Million USD | 1.87% |
| 2004 Q3 | 3.41 Million USD | 13.27% |
| 2004 Q4 | 4.33 Million USD | 27.03% |
| 2004 FY | 4.33 Million USD | 42.28% |
| 2003 FY | 3.04 Million USD | 9.09% |
| 2003 Q1 | 2.61 Million USD | -6.48% |
| 2003 Q3 | 2.67 Million USD | 10.45% |
| 2003 Q4 | 3.04 Million USD | 14.07% |
| 2003 Q2 | 2.42 Million USD | -7.42% |
| 2002 FY | 2.79 Million USD | 33.92% |
| 2002 Q2 | 1.7 Million USD | 3.65% |
| 2002 Q4 | 2.79 Million USD | 34.5% |
| 2002 Q1 | 1.64 Million USD | 0.0% |
| 2002 Q3 | 2.07 Million USD | 21.88% |
| 2001 Q2 | 1.68 Million USD | 16.62% |
| 2001 Q3 | 1.88 Million USD | 11.88% |
| 2001 Q1 | 1.44 Million USD | 0.56% |
| 2001 FY | 2.08 Million USD | 56.68% |
| 2000 Q1 | 1.33 Million USD | -25.0% |
| 2000 Q3 | 1.38 Million USD | 1.24% |
| 2000 Q2 | 1.37 Million USD | 3.0% |
| 2000 FY | 1.33 Million USD | -27.37% |
| 2000 Q4 | 1.43 Million USD | 3.38% |
| 1999 Q3 | 1.62 Million USD | -6.02% |
| 1999 Q2 | 1.72 Million USD | -5.83% |
| 1999 Q1 | 1.83 Million USD | 27.45% |
| 1999 FY | 1.83 Million USD | 83.4% |
| 1999 Q4 | 1.77 Million USD | 9.43% |
| 1998 Q4 | 1.43 Million USD | -19.07% |
| 1998 Q3 | 1.77 Million USD | 52.36% |
| 1998 Q2 | 1.16 Million USD | 16.7% |
| 1998 Q1 | 1 Million USD | 11.11% |
| 1998 FY | 1 Million USD | 49.54% |
| 1997 FY | 668.72 Thousand USD | 0.0% |
| 1997 Q4 | 900 Thousand USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Arrayit Corporation | 464.19 Thousand USD | 18.353% |
| Atlantic International Corp. | - USD | -Infinity% |
| Biocept, Inc. | 757 Thousand USD | 49.934% |
| Bioqual, Inc. | - USD | -Infinity% |
| CardioGenics Holdings Inc | -2385.00 USD | 15990.985% |
| DermTech, Inc. | 1 Million USD | 62.251% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 3.29 Million USD | 88.512% |
| HTG Molecular Diagnostics, Inc. | 909.32 Thousand USD | 58.321% |
| iMD Companies, Inc. | 38.31 Thousand USD | -889.143% |
| IDenta Corp. | 442.28 Thousand USD | 14.308% |
| Interpace Biosciences, Inc. | 1.22 Million USD | 69.112% |
| Integrative Health Technologies, Inc. | - USD | -Infinity% |
| InVitro International | 163.13 Thousand USD | -132.323% |
| Lumos Diagnostics Holdings Limited | 784 Thousand USD | 51.658% |
| Many Bright Ideas Technologies Inc. | -375.00 USD | 101166.667% |
| Medical Imaging Corp. | - USD | -Infinity% |
| NovelStem International Corp. | - USD | -Infinity% |
| Optigenex Inc. | 468.77 Thousand USD | 19.151% |
| PharmChem, Inc. | 391.93 Thousand USD | 3.301% |
| Proteome Sciences plc | 1.06 Million USD | 64.43% |
| Response Genetics, Inc | 133 Thousand USD | -184.962% |
| Rennova Health, Inc. | 242.64 Thousand USD | -56.195% |
| RushNet, Inc. | - USD | -Infinity% |
| ScreenPro Security Inc. | 73.89 Thousand USD | -412.876% |
| Stella Diagnostics Inc. | - USD | -Infinity% |
| StageZero Life Sciences Ltd. | 95.62 Thousand USD | -296.356% |
| Todos Medical Ltd. | 1.02 Million USD | 62.879% |